Michael Weiner, MD

Professor of radiology and biomedical imaging, medicine, psychiatry, and neurology at the University of California–San Francisco, principal investigator, Alzheimer's Disease Neuroimaging Initiative, and director, Brain Health Registr

Articles by Michael Weiner, MD

Michael Weiner, MD, professor of radiology and biomedical imaging, medicine, psychiatry, and neurology, University of California–San Francisco, principal investigator, Alzheimer's Disease Neuroimaging Initiative, and director, Brain Health Registry

Advancements in the Alzheimer Disease Field: Michael Weiner, MD

ByMichael Weiner, MD

August 27th 2021

The director of the Brain Health Registry discussed advancements in AD, following the publication of a systematic review on the predictors of Aß.

Michael Weiner, MD, professor of radiology and biomedical imaging, medicine, psychiatry, and neurology at the University of California–San Francisco, principal investigator, Alzheimer's Disease Neuroimaging Initiative; director, Brain Health Registry

A Systematic Review of the Prediction of Brain Amyloid Status: Michael Weiner, MD

ByMichael Weiner, MD

August 26th 2021

The principal investigator of the Alzheimer’s Disease Neuroimaging Initiative discussed a study published earlier this year, which aimed at identifying better ways to predict dichotomous Aß.

Michael Weiner, MD

Articles by Michael Weiner, MD

Advancements in the Alzheimer Disease Field: Michael Weiner, MD

A Systematic Review of the Prediction of Brain Amyloid Status: Michael Weiner, MD

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related Amyloid Pathology

Inside the Phase 3 MASCOT Trial: Lundbeck’s Push for the First Disease-Modifying MSA Therapy

Phase 2 OPAL Study to Test Muscle-Targeting Therapy Apitegromab in Infants With SMA

Decision-Making in De-Escalating Therapy for Multiple Sclerosis

Interim ROSSINI Data Highlight Foslevodopa/Foscarbidopa’s Impact in Advanced Parkinson Disease